Business Context and Reporting Period
Company: Community Health Systems, Inc. (CYH)
Filing Type: Form 8-K (Current Report)
Report Date: April 3, 2023 (Event Date: April 1, 2023)
Context: The Company reported the completion of a significant asset disposition involving the sale of Plateau Medical Center in Oak Hill, West Virginia.
Key Financial Metrics
- Transaction Proceeds: Approximately $92 million in cash received at the preliminary closing on March 31, 2023.
- Asset Sold: Substantially all assets of Plateau Medical Center (25 licensed beds).
- Buyer: Affiliates of Vandalia Health, Inc.
- Revenue/Profit/Cash Flow: The filing text does not provide specific revenue, profit, or cash flow figures for the reporting period; it references unaudited pro forma financial statements filed as Exhibit 99.1.
- Debt/Liquidity: Specific debt or liquidity metrics are not detailed in the text; the transaction resulted in a cash inflow of $92 million.
Material Changes
The primary material change is the divestiture of Plateau Medical Center. This transaction is classified as a significant disposition under Item 2.01 of Form 8-K. The sale removes the 25-bed facility from the Company's operational portfolio and generates immediate liquidity.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release (Exhibit 99.2) announcing the transaction completion.
- Pro Forma Information: Unaudited pro forma condensed consolidated financial statements for the year ended December 31, 2022, are included as Exhibit 99.1 to reflect the impact of the transaction.
- Risks and Contingencies: The filing includes standard disclaimers regarding the Asset Purchase Agreement, noting that representations and warranties were made solely for the agreement's purposes and may differ from an investor's view of materiality. No specific new risks or contingencies were detailed in the text beyond the transaction mechanics.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited pro forma financial statements to understand the impact on the 2022 fiscal year.
- Examine the Asset Purchase Agreement (Exhibit 2.1) for details on earn-outs, holdbacks, or contingent liabilities not captured in the $92 million preliminary closing figure.
- Verify the final closing status and any adjustments to the purchase price post-March 31, 2023.
- Assess the strategic rationale for the divestiture as outlined in the press release (Exhibit 99.2).